KaliVir Immunotherapeutics
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $14M
Investors
- 5
About KaliVir Immunotherapeutics
, operates as a biotechnology company that provides a therapeutic platform for the treatment of cancer patients. In August 2026, KaliVir Immunotherapeutics, Inc. Helena Chaye currently serving as CEO. KaliVir offers a potent, novel oncolytic platform called the Vaccinia Enhanced Template (VET™) that can preferentially infect and kill cancer cells. The company also provides oncolytic viral immunotherapy to treat cancer patients with a variety of tumor types. The company is a clinical-stage biotechnology business and does not publicly disclose commercial product revenue.
Who invested in KaliVir Immunotherapeutics
5 investors across 2 rounds
See all investors in KaliVir Immunotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KaliVir Immunotherapeutics
Who invested in KaliVir Immunotherapeutics?
KaliVir Immunotherapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KaliVir Immunotherapeutics raised?
KaliVir Immunotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did KaliVir Immunotherapeutics last raise money?
KaliVir Immunotherapeutics's most recent round on record is a Series A, in Aug 2026.
What does KaliVir Immunotherapeutics do?
, operates as a biotechnology company that provides a therapeutic platform for the treatment of cancer patients.
Where is KaliVir Immunotherapeutics headquartered?
KaliVir Immunotherapeutics is headquartered in Pittsburgh, US.
Which VCs invest in companies like KaliVir Immunotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at KaliVir Immunotherapeutics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like KaliVir Immunotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.